Related references
Note: Only part of the references are listed.Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
Tuomas Laukka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Marco Sciacovelli et al.
NATURE (2016)
MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling
Su Jung Song et al.
CELL (2013)
The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
Su Jung Song et al.
CELL STEM CELL (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)
Alexandra R. Grassian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations
Celine Loriot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Christian Frezza et al.
NATURE (2011)
Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
PJ Pollard et al.
HUMAN MOLECULAR GENETICS (2005)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)